ArticleFrontiers in immunology2022

The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.

Huiyang Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.